Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Amal Alwehaibe"'
Autor:
Naif Khalaf Alharbi, Jaffar A. Al-Tawfiq, Suliman Alghnam, Amal Alwehaibe, Abrar Alasmari, Suliman A. Alsagaby, Faisal Alsubaie, Majid Alshomrani, Fayssal M. Farahat, Mohammad Bosaeed, Ahmad Alharbi, Omar Aldibasi, Abdullah M. Assiri
Publikováno v:
Journal of Infection and Public Health, Vol 15, Iss 5, Pp 573-577 (2022)
Background: Two vaccines for COVID-19 have been approved and administered in the Kingdom of Saudi Arabia (KSA); Pfizer-BioNtech BNT162b2 and AstraZeneca-Oxford AZD1222 vaccines. The purpose of this study was to describe the real-world data on the out
Externí odkaz:
https://doaj.org/article/26349372c6fa4f929c4929c21b6d8612
Autor:
Naif Khalaf Alharbi, Jaffar A Al-Tawfiq, Amal Alwehaibe, Mohamed W Alenazi, Abdulrahman Almasoud, Abdullah Algaisi, Fahad A Alhumaydhi, Anwar M Hashem, Mohammad Bosaeed, Suliman A Alsagaby
Publikováno v:
Infection and Drug Resistance.
Naif Khalaf Alharbi,1,2 Jaffar A Al-Tawfiq,3â 5 Amal Alwehaibe,1 Mohamed W Alenazi,1 Abdulrahman Almasoud,1 Abdullah Algaisi,6 Fahad A Alhumaydhi,7 Anwar M Hashem,8,9 Mohammed Bosaeed,1,2,10 Suliman A Alsagaby11 1Vaccine Development Unit, King A
Autor:
Abdullah M. Assiri, Mohammad Bosaeed, Amal Alwehaibe, Jaffar A. Al-Tawfiq, Suliman A. Alsagaby, Faizah Alotaibi, Fayssal M. Farahat, Omar Aldibasi, Ahmad Alharbi, Naif Khalaf Alharbi, Suliman Alghnam, Majid Al-Shomrani, Abrar K Alasmari, Faisal Alsubaie
ObjectivesTo describe the real-world data on the effectiveness of Pfizer-BioNtech BNT162b2 and AstraZeneca-Oxford AZD1222 vaccines against COVID-19 in a large cohort in the Kingdom of Saudi Arabia (KSA).MethodsA total of 18,543 subjects received a si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0525c105216e6a67fb95258c01f3d16a
https://doi.org/10.1101/2021.09.18.21263262
https://doi.org/10.1101/2021.09.18.21263262